Insider Buying: Ansell Limited (ASX:ANN) Insider Buys 426 Shares of Stock

Ansell Limited (ASX:ANN) insider Debra (Debbie) Goodin bought 426 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The shares were acquired at an average price of A$35.10 ($21.80) per share, with a total value of A$14,952.17 ($9,287.06).

Debra (Debbie) Goodin also recently made the following trade(s):

• On Friday, February 21st, Debra (Debbie) Goodin purchased 1,427 shares of Ansell stock. The stock was bought at an average price of A$35.50 ($22.05) per share, for a total transaction of A$50,658.50 ($31,464.91).

Ansell Stock Performance

The company has a debt-to-equity ratio of 45.24, a quick ratio of 1.13 and a current ratio of 3.84. The stock has a market capitalization of $3.33 billion, a price-to-earnings ratio of 39.82, a P/E/G ratio of -14.40 and a beta of 0.46.

Ansell Increases Dividend

The business also recently declared a Interim dividend, which will be paid on Wednesday, March 5th. Investors of record on Wednesday, March 5th will be given a $0.353 dividend. The ex-dividend date is Thursday, February 13th. This is a boost from Ansell’s previous Interim dividend of $0.25. This represents a yield of 0.95%. Ansell’s payout ratio is 67.06%.

About Ansell

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.